20030502
 Health & Technology: Yamanouchi Again Replaced Key U.S. Official   By By Peter Landers, The Wall Street Journal,  May 2, 2003  Last year, Yamanouchi announced plans to sell its incontinence drug, which has tentatively been named Vesicare, with its own sales force. In an interview in June, Stephen Mader, then Yamanouchi's top non-Japanese executive in the U.S., said the company would hire 150 salespeople to pitch Vesicare to urologists and another 300 to market it to primary-care doctors.   
